Treatment of Laryngeal Papillomatosis with Cidofovir

Treatment of Laryngeal Papillomatosis with Cidofovir - Treatment of Laryngeal Papillomatosis with Cidofovir

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017863

Enrollment

Registered

2015-06-11

Start date

2015-06-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal Papillomatosis

Interventions

cidofovir 7.5mg/ml local injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pathologicaly diagnosed as larynx papilloma. Written infomed consent to useage of cidofovir.

Exclusion criteria

Exclusion criteria: Refused to useage of cidofovir.

Design outcomes

Primary

Measure	Time frame
clinical findings of larynx	—

Secondary

Measure	Time frame
GRBAS score	—

Countries

Japan

Contacts

Public ContactKiyoshi Misawa

HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE Depertment of otorhinolaryngology

kiyoshim@hama-med.ac.jp053-435-2659

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026